Open-house discount agreements for medicines 2025-02

Summary

The tender concerns discount agreements for medicines, arranged by lots covering the active substances, combinations of active substances, dosage forms, strengths or finished medicinal products specified for each lot. This is an open-house procedure: individual negotiations on the contract terms are not conducted and uniform conditions apply to all partners. The contract generally lasts for a maximum of 24 months, starting no earlier than 1 April 2025, and ends no later than 31 March 2027. An eligible company may join the procedure at any time during the contract period. No partner is granted exclusivity, and the exact lots, medicines and contractual conditions must be checked in the tender documents.